跳至主要内容
临床试验/DRKS00015843
DRKS00015843招募中不适用

Collection of samples for the development and validation of analytical methods in Clinical Pharmacology (KPE37) - KPE37

ehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg0 个研究点目标入组 120 人开始时间: 2018年12月12日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • written informed consent

排除标准

  • medical contraindication against the planned type of sample collection, clinical relevant anemia, clinical relevant abnormalities of the urinary tract, clinical relevant abnormalities of the mouth or the salivary glands, acute diseases, pregnant or breast-feeding women, employees of the department of Clinical Pharmacology at the Friedrich-Alexander-Universität Erlangen-Nürnberg, students still having to take exams at the department of Clinical Pharmacology (especially students studying medicine, dentistry, molecular medicine, pharmacy or medical process management)

研究者

发起方
ehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg

相似试验

已完成
不适用
Sample collection for an assay development to determine HSV-specific T-cell responses in blood samples from HSV-2 infected individuals and HSV-1 + HSV-2 infected individualsgenital herpesoral herpesB00Herpesviral [herpes simplex] infections
DRKS00031143Heidelberg ImmunoTherapeutics GmbH29
招募中
不适用
Sample Collection Study for Scientific Evaluation of Laboratory Interference of CyFlow Antibodies for Flow CytometrySample Collection Study for Scientific Evaluation of Laboratory Interference of CyFlow™ Antibodies for Flow Cytometry
DRKS00033260PSHI Praxis GmbH65
尚未招募
不适用
Prospective sample collection, data collection and analysis for the clinical applicability of immunome profiles in the discrimination and therapy monitoring of COVID-19 patients in different disease stages as well as for the identification and characterization of long-term consequences of a SARS-CoV-2 infection in comparison to patients with a respiratory non-COVID-19 viral infectious disease and healthy controls.U07.1COVID-19, virus identified
DRKS00024422Fraunhofer ITMP200
已完成
不适用
Prospective collection of data and biomaterial of COVID-19 at the location WürzburgU07.1COVID-19, virus identified
DRKS00022402niversitätsklinikum Würzburg94
已完成
不适用
Registration and sample collection for identification of genetic and public health characteristics of the major birth defects in koreaCongenital malformations, deformations and chromosomal abnormalities
KCT0003671Korea Centers for Disease Control and Prevention1,400